MDK and glioblastoma: Previous studies have demonstrated that the MK signaling pathway played a pivotal role in the malignant progression of GBM through multiple mechanisms, including mediating TME remodeling, inducing the formation of an immunosuppressive microenvironment, and driving malignant tumor behaviors (86).